Compare EBS & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | TG |
|---|---|---|
| Founded | 1998 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.8M | 262.4M |
| IPO Year | 2006 | 1994 |
| Metric | EBS | TG |
|---|---|---|
| Price | $6.49 | $7.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 169.0K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 125.83 | ★ 151.06 |
| EPS | N/A | ★ 0.34 |
| Revenue | $742,900,000.00 | ★ $800,821,000.00 |
| Revenue This Year | $1.29 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.53 |
| Revenue Growth | N/A | ★ 8.29 |
| 52 Week Low | $4.36 | $6.25 |
| 52 Week High | $14.06 | $10.53 |
| Indicator | EBS | TG |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 46.37 |
| Support Level | $4.36 | $7.57 |
| Resistance Level | $8.59 | $8.12 |
| Average True Range (ATR) | 0.27 | 0.23 |
| MACD | 0.26 | -0.04 |
| Stochastic Oscillator | 97.70 | 30.87 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.